315 related articles for article (PubMed ID: 19682779)
1. Urinary arsenic species and CKD in a Taiwanese population: a case-control study.
Hsueh YM; Chung CJ; Shiue HS; Chen JB; Chiang SS; Yang MH; Tai CW; Su CT
Am J Kidney Dis; 2009 Nov; 54(5):859-70. PubMed ID: 19682779
[TBL] [Abstract][Full Text] [Related]
2. Micronutrients and lifestyles in Taiwanese patients with stage 3 to 5 chronic kidney disease.
Chiang SS; Tai CW; Chung CJ; Shiue HS; Chen JB; Su CT; Hsueh YM
Nutrition; 2010 Mar; 26(3):276-82. PubMed ID: 19819111
[TBL] [Abstract][Full Text] [Related]
3. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
[TBL] [Abstract][Full Text] [Related]
4. Serum beta-carotene level, arsenic methylation capability, and incidence of skin cancer.
Hsueh YM; Chiou HY; Huang YL; Wu WL; Huang CC; Yang MH; Lue LC; Chen GS; Chen CJ
Cancer Epidemiol Biomarkers Prev; 1997 Aug; 6(8):589-96. PubMed ID: 9264271
[TBL] [Abstract][Full Text] [Related]
5. Urinary 8-hydroxydeoxyguanosine and urothelial carcinoma risk in low arsenic exposure area.
Chung CJ; Huang CJ; Pu YS; Su CT; Huang YK; Chen YT; Hsueh YM
Toxicol Appl Pharmacol; 2008 Jan; 226(1):14-21. PubMed ID: 17950770
[TBL] [Abstract][Full Text] [Related]
6. Urinary arsenic profile affects the risk of urothelial carcinoma even at low arsenic exposure.
Pu YS; Yang SM; Huang YK; Chung CJ; Huang SK; Chiu AW; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):99-106. PubMed ID: 17196235
[TBL] [Abstract][Full Text] [Related]
7. Plasma folate level, urinary arsenic methylation profiles, and urothelial carcinoma susceptibility.
Huang YK; Pu YS; Chung CJ; Shiue HS; Yang MH; Chen CJ; Hsueh YM
Food Chem Toxicol; 2008 Mar; 46(3):929-38. PubMed ID: 18054417
[TBL] [Abstract][Full Text] [Related]
8. Arsenic exposure, urinary arsenic speciation, and the incidence of urothelial carcinoma: a twelve-year follow-up study.
Huang YK; Huang YL; Hsueh YM; Yang MH; Wu MM; Chen SY; Hsu LI; Chen CJ
Cancer Causes Control; 2008 Oct; 19(8):829-39. PubMed ID: 18351295
[TBL] [Abstract][Full Text] [Related]
9. Protective effects of plasma alpha-tocopherols on the risk of inorganic arsenic-related urothelial carcinoma.
Chung CJ; Pu YS; Chen YT; Su CT; Wu CC; Shiue HS; Huang CY; Hsueh YM
Sci Total Environ; 2011 Feb; 409(6):1039-45. PubMed ID: 21227482
[TBL] [Abstract][Full Text] [Related]
10. Arsenic methylation capability and hypertension risk in subjects living in arseniasis-hyperendemic areas in southwestern Taiwan.
Huang YK; Tseng CH; Huang YL; Yang MH; Chen CJ; Hsueh YM
Toxicol Appl Pharmacol; 2007 Jan; 218(2):135-42. PubMed ID: 17173945
[TBL] [Abstract][Full Text] [Related]
11. Detection and awareness of moderate to advanced CKD by primary care practitioners: a cross-sectional study from Italy.
Minutolo R; De Nicola L; Mazzaglia G; Postorino M; Cricelli C; Mantovani LG; Conte G; Cianciaruso B
Am J Kidney Dis; 2008 Sep; 52(3):444-53. PubMed ID: 18468747
[TBL] [Abstract][Full Text] [Related]
12. Effect of plasma homocysteine level and urinary monomethylarsonic acid on the risk of arsenic-associated carotid atherosclerosis.
Wu MM; Chiou HY; Hsueh YM; Hong CT; Su CL; Chang SF; Huang WL; Wang HT; Wang YH; Hsieh YC; Chen CJ
Toxicol Appl Pharmacol; 2006 Oct; 216(1):168-75. PubMed ID: 16806340
[TBL] [Abstract][Full Text] [Related]
13. Association of oxidative stress with arsenic methylation in chronic arsenic-exposed children and adults.
Xu Y; Wang Y; Zheng Q; Li X; Li B; Jin Y; Sun X; Sun G
Toxicol Appl Pharmacol; 2008 Oct; 232(1):142-9. PubMed ID: 18640141
[TBL] [Abstract][Full Text] [Related]
14. Metabolic syndrome and the development of CKD in American Indians: the Strong Heart Study.
Lucove J; Vupputuri S; Heiss G; North K; Russell M
Am J Kidney Dis; 2008 Jan; 51(1):21-8. PubMed ID: 18155529
[TBL] [Abstract][Full Text] [Related]
15. CKD as a risk factor for bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma.
Chung SD; Huang KH; Lai MK; Huang CY; Chen CH; Pu YS; Yu HJ; Chueh SC
Am J Kidney Dis; 2007 Nov; 50(5):743-53. PubMed ID: 17954287
[TBL] [Abstract][Full Text] [Related]
16. The relationship between obesity, insulin and arsenic methylation capability in Taiwan adolescents.
Su CT; Lin HC; Choy CS; Huang YK; Huang SR; Hsueh YM
Sci Total Environ; 2012 Jan; 414():152-8. PubMed ID: 22104380
[TBL] [Abstract][Full Text] [Related]
17. CKD and risk of hospitalization and death with pneumonia.
James MT; Quan H; Tonelli M; Manns BJ; Faris P; Laupland KB; Hemmelgarn BR;
Am J Kidney Dis; 2009 Jul; 54(1):24-32. PubMed ID: 19447535
[TBL] [Abstract][Full Text] [Related]
18. Levels of urinary total and speciated arsenic in the US population: National Health and Nutrition Examination Survey 2003-2004.
Caldwell KL; Jones RL; Verdon CP; Jarrett JM; Caudill SP; Osterloh JD
J Expo Sci Environ Epidemiol; 2009 Jan; 19(1):59-68. PubMed ID: 18523458
[TBL] [Abstract][Full Text] [Related]
19. Relationship of uric acid with progression of kidney disease.
Chonchol M; Shlipak MG; Katz R; Sarnak MJ; Newman AB; Siscovick DS; Kestenbaum B; Carney JK; Fried LF
Am J Kidney Dis; 2007 Aug; 50(2):239-47. PubMed ID: 17660025
[TBL] [Abstract][Full Text] [Related]
20. Effect of pentoxifylline in addition to losartan on proteinuria and GFR in CKD: a 12-month randomized trial.
Lin SL; Chen YM; Chiang WC; Wu KD; Tsai TJ
Am J Kidney Dis; 2008 Sep; 52(3):464-74. PubMed ID: 18617301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]